Nanocarriers based therapy and diagnosis of brain diseases: cross the blood-brain barrier
Open Access
- 28 November 2025
- journal article
- Published by Taylor & Francis in Science and Technology of Advanced Materials
- Vol. 26 (1)
Abstract
The blood-brain barrier (BBB) is the protective interface that isolates the central nervous system from circulating blood, which restricts approximately 98% of small molecule drugs and nearly all large molecules from entering the brain. Current methods to bypass the BBB, such as laser-guided interstitial thermal therapy and magnetic resonance guided focused ultrasound, are fraught with risks like impairing BBB integrity and brain damage, and are not suitable for long-term treatment. Nanocarriers have emerged as promising tools due to their ability to enhance drug delivery across the BBB while minimizing systemic toxicity. These nanocarriers leverage mechanisms including receptor-mediated, carrier-mediated, cell mediated and extra-stimuli mediated transport to improve BBB traverse and brain targeting. The review evaluates these strategies separately, discussing their potential and limitations for clinical application, and highlights recent advancements in integrating and optimizing nanocarriers utilizing synergistic strategies for the treatment and diagnosis of neurological disorders, including tumors, Alzheimer’s disease, Parkinson’s disease, and brain infections.Keywords
Funding Information
- National Natural Science Foundation of China (82104357)
- China Postdoctoral Science Foundation (2021M702292, 2022T150441)
- Shenzhen Science and Technology Program (KJZD20240903102714019)
This publication has 162 references indexed in Scilit:
- Engineered Cell Membrane‐Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune ModulationAdvanced Healthcare Materials, 2024
- Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese MedicineAdvanced Science, 2024
- Bacteria‐Derived Outer‐Membrane Vesicles Hitchhike Neutrophils to Enhance Ischemic Stroke TherapyAdvanced Materials, 2023
- Study on the Role of an Erythrocyte Membrane‐Coated Nanotheranostic System in Targeted Immune Regulation of Alzheimer's DiseaseAdvanced Science, 2023
- Engineered Extracellular Vesicles with SHP2 High Expression Promote Mitophagy for Alzheimer's Disease TreatmentAdvanced Materials, 2022
- An Activatable and Reversible Virus‐Mimicking NIR‐II Nanoprobe for Monitoring the Progression of Viral EncephalitisAngewandte Chemie International Edition, 2022
- Functionalized Macrophage Exosomes with Panobinostat and PPM1D‐siRNA for Diffuse Intrinsic Pontine Gliomas TherapyAdvanced Science, 2022
- Protease Responsive Nanogels for Transcytosis across the Blood−Brain Barrier and Intracellular Delivery of Radiopharmaceuticals to Brain Tumor CellsAdvanced Healthcare Materials, 2021
- Catalytic‐Enhanced Lactoferrin‐Functionalized Au‐Bi2Se3 Nanodots for Parkinson's Disease Therapy via Reactive Oxygen Attenuation and Mitochondrial ProtectionAdvanced Healthcare Materials, 2021
- Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological DiseasesAdvanced Materials, 2018